References from scientific journals

Ipratropium bromide.

Massey KL, Gotz VP. Massey KL, et al. Drug Intell Clin Pharm. 1985 Jan;19(1):5-12. doi: 10.1177/106002808501900102. Drug Intell Clin Pharm. 1985. PMID: 3155676 Review.

In the treatment of chronic bronchitis, however, ipratropium appears at least as effective as, and possibly superior to, the sympathomimetics. ...In addition, combination therapy may prove to be another important use of ipratropium in the management of COPD....
In the treatment of chronic bronchitis, however, ipratropium appears at least as effective as, and possibly superior to, the sympatho …

Ipratropium bromide.

Gross NJ. Gross NJ. N Engl J Med. 1988 Aug 25;319(8):486-94. doi: 10.1056/NEJM198808253190806. N Engl J Med. 1988. PMID: 2970009 Review. No abstract available.


Intranasal ipratropium bromide for the common cold.

AlBalawi ZH, Othman SS, Alfaleh K. AlBalawi ZH, et al. Cochrane Database Syst Rev. 2013 Jun 19;2013(6):CD008231. doi: 10.1002/14651858.CD008231.pub3. Cochrane Database Syst Rev. 2013. PMID: 23784858 Free PMC article. Review.

There is no proven cure for the common cold and symptomatic relief is the mainstay of treatment. The use of intranasal ipratropium bromide (IB) has been addressed in several studies and might prove an effective treatment for the common cold. ...
There is no proven cure for the common cold and symptomatic relief is the mainstay of treatment. The use of intranasal ipratropium br …

Intranasal ipratropium: literature abstracts and comments.

Mygind N, Borum P. Mygind N, et al. Rhinol Suppl. 1989;9:37-44. Rhinol Suppl. 1989. PMID: 2534054 Review.

There was a significant reduction in nasal hypersecretion during ipratropium treatment. Fourteen patients preferred the ipratropium period, three the placebo period and three had no preference. There were no systemic or local side effects. Ipratropium was eff …
There was a significant reduction in nasal hypersecretion during ipratropium treatment. Fourteen patients preferred the ipratropiu …

Intranasal ipratropium bromide for the common cold.

Albalawi ZH, Othman SS, Alfaleh K. Albalawi ZH, et al. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008231. doi: 10.1002/14651858.CD008231.pub2. Cochrane Database Syst Rev. 2011. PMID: 21735425 Updated. Review.

There is no proven cure for the common cold and symptomatic relief is the mainstay of treatment. The use of intranasal ipratropium bromide (IB) has been addressed in several studies and might prove an effective treatment for the common cold. ...
There is no proven cure for the common cold and symptomatic relief is the mainstay of treatment. The use of intranasal ipratropium br …

Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.

Cole JM, Sheehan AH, Jordan JK. Cole JM, et al. Ann Pharmacother. 2012 Dec;46(12):1717-21. doi: 10.1345/aph.1R283. Epub 2012 Nov 20. Ann Pharmacother. 2012. PMID: 23170031 Review.

The peak response with fenoterol was significantly higher than with ipratropium (FEV(1) difference = 84 mL). Another study reported a mean difference in FEV(1) of 81 mL (95% CI 27 to 136) with albuterol versus placebo and a mean difference in FEV(1) of 68 mL (95% CI 3 to 1 …
The peak response with fenoterol was significantly higher than with ipratropium (FEV(1) difference = 84 mL). Another study reported a …

Ipratropium bromide in chronic bronchitis/emphysema. A review of the literature.

Lakshminarayan S. Lakshminarayan S. Am J Med. 1986 Nov 14;81(5A):76-80. doi: 10.1016/0002-9343(86)90467-5. Am J Med. 1986. PMID: 2947464 Review.

Many studies have evaluated the efficacy of ipratropium bromide in chronic obstructive pulmonary disease (COPD). Single-agent studies have shown ipratropium to be both safe and effective in COPD. Several studies have compared ipratropium with sympathomimetic …
Many studies have evaluated the efficacy of ipratropium bromide in chronic obstructive pulmonary disease (COPD). Single-agent studies …

Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.

Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS. Pakes GE, et al. Drugs. 1980 Oct;20(4):237-66. doi: 10.2165/00003495-198020040-00001. Drugs. 1980. PMID: 6448137 Review.

Ipratropium bromide is an anticholinergc bronchodilator administered by inhalation. ...Usual inhaled doses of ipratropium were well tolerated in all studies. Ipratropium thus appears to be a suitable alternative to beta 2-adrenoceptor agonist drugs in patient …
Ipratropium bromide is an anticholinergc bronchodilator administered by inhalation. ...Usual inhaled doses of ipratropium were …

Ipratropium bromide in asthma. A review of the literature.

Schlueter DP. Schlueter DP. Am J Med. 1986 Nov 14;81(5A):55-60. doi: 10.1016/0002-9343(86)90463-8. Am J Med. 1986. PMID: 2947461 Review.

In comparative studies of asthma, ipratropium bromide has been shown to have a slower onset of bronchodilator action but a longer duration of effect than beta agonists. An additive effect of ipratropium and beta agonists has been demonstrated, in addition to prolong …
In comparative studies of asthma, ipratropium bromide has been shown to have a slower onset of bronchodilator action but a longer dur …

Ipratropium bromide in COPD and asthma.

Atsmon J. Atsmon J. Am J Med Sci. 1988 Aug;296(2):140-2. doi: 10.1097/00000441-198808000-00015. Am J Med Sci. 1988. PMID: 2969679 Review. No abstract available.